Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 3/Signature 1
From BugSigDB
Reviewed Marked as Reviewed by Peace Sandy on 2024-4-9
Source: Table 2 and Text
Description: 16S rRNA analysis showing the differences in the relative abundance of microbiota composition between Parkinson's Disease Patients with elevated levels of fecal Calprotectin and Calprotectin Negative Healthy Controls.
Abundance in Group 1: increased abundance in Parkinson's Disease Patients with elevated Calprotectin levels
| NCBI | Quality Control | Links |
|---|---|---|
| Finegoldia | ||
| Peptoniphilus | ||
| Peptostreptococcaceae |
Revision editor(s): FaithAlexander, WikiWorks
